Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose intravenous dexamethasone for pain after total knee replacement
2016-002251-13Phase 4Terminated
- Sponsor
- Oulu University Hospital
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in knee osteoarthritis (OA), sponsored by Oulu University Hospital. Primary endpoint: Dynamic pain during walking/standing at 24 hours postoperatively. Started Oct 2016; status: terminated.
02
Drugs
dexamethasone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-002251-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002251-13.